BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 18596939)

  • 1. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
    Wang X; Tang S; Le SY; Lu R; Rader JS; Meyers C; Zheng ZM
    PLoS One; 2008 Jul; 3(7):e2557. PubMed ID: 18596939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs are biomarkers of oncogenic human papillomavirus infections.
    Wang X; Wang HK; Li Y; Hafner M; Banerjee NS; Tang S; Briskin D; Meyers C; Chow LT; Xie X; Tuschl T; Zheng ZM
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4262-7. PubMed ID: 24591631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
    Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
    Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of known and novel small RNAs in human cervical cancer.
    Lui WO; Pourmand N; Patterson BK; Fire A
    Cancer Res; 2007 Jul; 67(13):6031-43. PubMed ID: 17616659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated microRNAs involved in the progression of cervical neoplasm.
    Zeng K; Zheng W; Mo X; Liu F; Li M; Liu Z; Zhang W; Hu X
    Arch Gynecol Obstet; 2015 Oct; 292(4):905-13. PubMed ID: 25851497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
    Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
    Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
    Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
    Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
    Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expressions in HPV-induced cervical dysplasia and cancer.
    Gocze K; Gombos K; Kovacs K; Juhasz K; Gocze P; Kiss I
    Anticancer Res; 2015 Jan; 35(1):523-30. PubMed ID: 25550598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.
    Wilting SM; Snijders PJ; Verlaat W; Jaspers A; van de Wiel MA; van Wieringen WN; Meijer GA; Kenter GG; Yi Y; le Sage C; Agami R; Meijer CJ; Steenbergen RD
    Oncogene; 2013 Jan; 32(1):106-16. PubMed ID: 22330141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
    Zhu YK; Cheng N; Hu Y; Cen YZ
    Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
    Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
    Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
    Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell.
    Yu DS; Song XL; Yan C
    Kaohsiung J Med Sci; 2021 May; 37(5):402-410. PubMed ID: 33493381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
    Liang C; Ding J; Yang Y; Deng L; Li X
    Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.